Author

Karina Durso-Cain

Loyola University Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

Harel DahariiD· 2 shared Susan L. UprichardiD· 2 shared Adam A. C. BurnsiD· 1 shared Alan S. PerelsoniD· 1 shared Alexandra Kamm· 1 shared Chise TatenoiD· 1 shared Evan Cudone· 1 shared Jonathan OzikiD· 1 shared

Activity by Year

2021-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Harel DahariORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Modeling in vitro cell-to-cell spread of hepatitis C viral infection using an agent-based approach

Zhenzhen Shi, Adam A. C. Burns, Evan Cudone, Alexandra Kamm, Karina Durso-Cain, Nicholson T. Collier, Jonathan Ozik, Susan L. Uprichard, Harel Dahari

This paper develops an agent-based model to simulate HCV cell-to-cell spread in vitro, incorporating cell proliferation, size changes, and foci merging, and shows it fits experimental data well.

bioRxiv · Jun 6, 2026 · PreprintMicrobiology

Understanding hepatitis B virus dynamics and the antiviral effect of interferon-alpha treatment in humanized chimeric mice

Laëtitia Canini, Yuji Ishida, Masataka Tsuge, Karina Durso-Cain, Tje Lin Chung, Chise Tateno, Alan S. Perelson, Susan L. Uprichard, Kazuaki Chayama, Harel Dahari

The paper models HBV kinetics in humanized mice treated with interferon-alpha, lamivudine, or both, revealing biphasic viral decline and distinct treatment effects on HBV DNA synthesis.

Journal of Virology · Apr 28, 2021Peer-reviewedSystems Biology